Centinel Spine in the News: Spine Surgeon Philip Saville, MD Performs Cervical Total Disc Replacement Surgery Using System that Allows Matching the Disc to the Patient Anatomy
“The old adage of ONE SIZE FITS ALL, does not apply when it comes to a person’s anatomy, and this is especially true for disc replacements. Every person is unique, so Centinel Spine’s portfolio of cervical discs allows me to select the device to match any individual’s vertebral endplate structure and maintain motion.”
– Dr. Philip Saville (from the article)
Source: Saville Spine Institute
Spine Surgeon Philip Saville, MD today announced a successful implantation of the prodisc® C Vivo Cervical Total Disc Replacement (TDR) product. The product was approved in July of 2022 by the U.S. Food and Drug Administration (FDA) for 1-level indications and is part of a portfolio of four FDA approved prodisc® C products that allow surgeons to select the implant that best matches a patient’s anatomy and level of disease.
The prodisc® C Vivo procedure was performed at Palm Beach Gardens Regional Surgery Center on a 55 year-old male. The patient was experiencing neck pain along with radiating discomfort and tingling down their arm that was not resolved through conservative care methods. Dr. Saville recognized the patient as a Cervical Total Disc Replacement candidate which allowed them to maintain motion in the affected area, as opposed to a traditional Cervical Fusion.
As an advocate of Disc Replacement procedures in general, the new prodisc® C portfolio of FDA approved devices provides Dr. Saville optionality for his patients. “The old adage of ONE SIZE FITS ALL, does not apply when it comes to a person’s anatomy, and this is especially true for disc replacements.” stated Saville. “Every person is unique, so Centinel Spine’s portfolio of Cervical Discs allows me to select the device to match any individual’s vertebral endplate structure and maintain motion.”
The prodisc® C Vivo system is manufactured by Centinel Spine and has been in clinical use outside the U.S. since 2009 and is currently one of the most frequently implanted TDR devices outside of the U.S. The device has keel-less endplates and combines a unique anatomically designed superior endplate with lateral spikes to optimize fit and provide immediate fixation. The prodisc® C Vivo device incorporates prodisc® CORE technology, the basis behind predictable clinical outcomes of the prodisc® platform after 30 years and over 225,000 implantations worldwide.
READ THE FULL STORY AT SAVILLE SPINE INSTITUTE WEBSITE
These third party links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by Centinel Spine of any of the content, views, or privacy policies of the third party site. Centinel Spine bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links. Please contact the external site for answers to questions regarding its content.
Categories
